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The mitochondrial enzyme FAD-linked glycerophosphate dehydrogenase plays a key role in the glucose-sensing device of the insulin-producing 
pancreatic B-cell. Its activity was found to be decreased in islet, but not liver, homogenates of BL / KS-dbldb mice, in which diabetes mellitus 
represents an inherited disease. The decreased activity of FAD-linked glycerophosphate dehydrogenase contrasted with a normal activity of 
glutamate dehydrogenase and 2-ketoglutarate dehydrogenase in the islets of dbldb mice. It is proposed that a site-specific defect of FAD-linked 
glycerophosphate dehydrogenase in the pancreatic B-cell might represent a far-from-uncommon causal or contributing factor in the pathogenesis 
of non-insulin-dependent diabetes mellitus. 
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1. INTRODUCTION 
The mitochondrial enzyme FAD-linked glycero- 
phosphate dehydrogenase (m-GDH) plays a key role in 
the glucose-sensing device of the pancreatic B-cells [ 1,2]. 
It catalyzes the rate-limiting reaction in the glycerol 
phosphate shuttle and its activation by Ca” accounts 
for the preferential stimulation of oxidative glycolysis 
in pancreatic islets exposed to increasing concentrations 
of ~-glucose [3,4]. As a result, the generation of ATP, 
which couples metabolic to cationic events in the proc- 
ess of glucose-stimulated insulin release, is markedly 
increased through both accelerated circulation in the 
glycerol phosphate shuttle and enhanced oxidation of 
glucose-derived pyruvate. 
In adult rats which were injected with streptozotocin 
during the neonatal period, the activity of m-GDH is 
severely decreased in islet, but not liver, homogenates 
[5]. This coincides, in intact islets, with an impaired 
circulation in the glycerol phosphate shuttle and a de- 
creased contribution of both oxidative glycolysis and 
pyruvate oxidation to total n-glucose utilization 15-71. 
Such metabolic anomalies are thought to account for 
the preferential alteration of the B-cell secretory re- 
sponse to o-glucose, as distinct from other nutrient or 
non-nutrient secretagogues, found in this animal model 
of non-insulin-dependent diabetes [S-l 11. The present 
report reveals that the activity of m-GDH is also de- 
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creased in islets of diabetic mice, in which diabetes mel- 
litus represents an inherited, rather than drug-induced, 
disease. 
2. MATERIALS AND METHODS 
Diabetes and control mice from the Diabetes Forschungsinstitut at 
the University of Diisseldorf (Germany) had free access to food and 
water up to the time of sacrifice. Diabetic mice were either C57BL I 
KsJ-ribidh or C57BL I Kd-+&/+db mice, 1.e. diabetic mice in which 
the misty gene (m) is maintained in repulsion with diabetes (db). Dia- 
bettc mice of both lines are here referred to as dhldb, whereas +/+, 
db?/+, and +db?h+ mice are referred to as controls. 
The method used to measure plasma glucose and insulin concentra- 
tions [l&13], to isolate islets [14], to assess the acttvtty of m-GDH by 
either a radioisotopic [1] or calorimetric [15] procedure and to measure 
the activity of glutamate dehydrogenase [ 16].2-ketoglutarate d hydro- 
genase [17], glutamate-pyruvate transaminase [18] and glutamate-ox- 
alacetate transaminase [18] were previously described in the cited 
references. Both islets (2 islets/PI) and liver (100 mg wet wtlml) were 
homogenized in a HEPES-NaOH buffer (20 mM, pH 7.4) containing 
250 mM sucrose and 2 mM EGTA. After removal of an aliquot of the 
tissue extract for protein determination [19], the homogenate was 
mixed with an equal volume of a solution containing 4 mM t-cysteine 
and 0.04% (w/v) bovine serum albumin. All enzymatic assays were 
conducted m the absence of Ca”, the final concentrations of sub- 
strates and co-factors mounting to 0.5 mM L-[2-3HJ~y~rol-3-phos- 
phate and 0.05 mM FAD in the radioisotopic assay of m-GDH, 10.0 
mM L-glycerol-3-phosphate and 2.0 mM 2-(4-iodophenyl)-3-(4-nitro- 
phenol)-5-phenyltetrazolium chloride in the calorimetric assay of m- 
GDH, 0.7 mM [U-‘4C]2-ketogIutarate, 50 mM ammonium acetate. 0.3 
mM NADPH and 1 .O mM ADP in the assay of glutamate dehydroge- 
nase, 0.5 mM [I-‘*Cl2-ketoglutarate, 1.0 mM NAD’, 0.5 mM coen- 
zyme A and 0.2 mM cocarboxylase m the assay of 2-ketoglutarate 
dehydrogenase, 2.5 mM [U-‘4C]2-ketoglutarate, 0.7 mM pyridoxal 
phosphate and either 24 mM L-alanine or L-aspartate in the assay of 
glutamate-pyruvate and glutamate-oxalacetate transaminases. All re- 
sults are presented as the mean value (2 S.E.M.) together with the 
number of individual observations (n). 
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3. RESULTS 
As shown in Table I, pancreatic islets were isolated 
from 64 control mice (30 males and 34 females), 8.4 + 
0.1 week-old (range 5 to 10 weeks) and 43 diabetic mice 
(20 males and 23 females). Except for one batch of islets 
(D4) obtained from 4 older diabetic animals (18 weeks), 
the mean age of the diabetic mice (8.5 + 0.4 weeks; it = 
39) was virtually identical to that of the control animals. 
Fifteen batches of 150 to 360 islets (mean: 256 ? 17 
islets) were obtained, each from 4 to 12 mice of compa- 
rable age and identical genetic background. The plasma 
glucose and insulin concentrations were measured in 
pooled samples obtained from several or all mice used 
to prepare each batch of islets. The plasma glucose 
concentration averaged 31.3 2 2.1 mM (n = 12) in dia- 
betic mice, as compared (P c 0.001) to 9.8 + 0.2 mM 
(n = 14) in control animals. The plasma insulin concen- 
tration averaged 215 f 32 PUlml (n = 12) in diabetic 
animals, as distinct (P < 0.001) from 37 ? 5 PUlml 
(n = 14) in control mice. At comparable age, the diabetic 
mice were also heavier (P < 0.001) than control animals, 
with mean values of 39.2 ? 1.8 g (n = 24) and 23.1 + 0.4 
g (n = 58) respectively. 
The results of enzymic measurements in islets and 
liver homogenates are summarized in Table II. The is- 
lets from dbldb mice displayed a lower activity of m- 
GDH than those from control animals. The protein 
content and the activities of both glutamate dehydroge- 
nase and 2-ketoglutarate dehydrogenase were not sig- 
nificantly different in islets from control and diabetes 
mice. No decrease in m-GDH activity was found in the 
liver of the dbldb mice, as assessed by either a radioiso- 
topic or calorimetric procedure. As expected from the 
intrinsic properties of the enzyme [ 151, the reaction ve- 
locity was higher in the calorimetric than radioisotopic 
assay. The paired ratio between the measurements made 
by calorimetric and radioisotopic procedures was not 
significantly different in control and diabetic mice, 
averaging respectively 54.8 + 2.3 (n = 27) and 55.0 ? 3.4 
(n = 24). In liver homogenates, the sole significant dif- 
ferences consisted in somewhat higher activity of gluta- 
mate-pyruvate transaminase, glutamate-oxalacetate 
transaminase and 2-ketoglutarate dehydrogenase in dbl 
db than control mice. 
4. DISCUSSION 
The process of glucose-induced insulin release from 
incubated pieces of pancreatic tissue is impaired in 7-9 
week-old dbldb mice [20]. The enhancing action of theo- 
phylline upon glucose-stimulated insulin secretion is 
preserved, however, in these diabetic animals [20]. The 
present findings suggest hat the preferential alteration 
of the B-cell secretory response to n-glucose could be 
caused, or at least favoured, by a decrease of m-GDH 
activity in the islets from dbldb mice. 
In pure B-cells prepared from normal rats, the activ- 
ity of m-GDH, when expressed relative to DNA con- 
tent, is about 10 times higher than in islet non-B cells 
[21]. The decreased activity of this enzyme in the islets 
of dbldb mice is unlikely, however, to be substantially 
attributable to a decreased contribution of B-cells rela- 
tive to total islet mass. Previous studies on both B-cell 
replication and volume density of the different cell types 
in the islets indeed indicate that a reduction in the num- 
ber of islet B-cells occurs only in older dbldb mice [22- 
24]. Furthermore, even in dbldb mice as old as 7-8 
Table I 
Genetic and metabolic status of mice used for the preparation of islet batches from control (C, to C,) or diabetic (D, to D,) animals 
Sample 
(no.) 
Mice 
(n) 
o/o Genetic 
status 
Age 
(weeks) 
Body wt 
(g) 
Plasma glucose Plasma insulin 
(mM) @U/ml) 
Islets 
(n) 
Cl 
c2 
c3 
c4 
CS 
C6 
C7 
Dl 
D2 
D3 
D4 
D5 
D6 
D7 
D8 
6’ 313 
6 412 
12 319 
10 0110 
10 10/o 
10 o/10 
10 10/o 
214 +dbl+db 
213 +dbl+db 
113 +dbl+db 
212 dbldb 
6/O +dbl+db 
O/6 +dbl+db 
6/O +dbl+db 
115 +dbl+db 
db?l+ 
+I+ 
+db?lm+ 
dbl+ 
dbl+ 
dbl+ 
dbl+ 
5-6 N.D.b 10.2 35 150 
8-9 21.8 f 0.9 9.779.9 2626 200 
7-10 22.3 f 0.8 8.3-9.1-9.8 43-55-58 300 
9 20.8 + 0.4 9.1-9.5 20-23 350 
9 25.5 f 0.3 10.611.4 41-77 240 
9 21.7 f 0.6 9.2-9.2 1630 360 
9 25.9 f 0.7 9.8-10.8 3668 320 
67 
8 
13 
18 
5-11” 
5-11” 
5-11” 
5-11” 
N.D. 27.1 377 300 
N.D. 22.6 110 230 
N.D. 29.4 142 300 
N.D. 29.6 178 300 
44.3 f 2.3 35.141.7 1399270 230 
39.2 f 5.4 31.3-31.6 83-179 200 
41.0 f 1.8 40.W2.8 150-192 200 
32.3 f 3.1 21.9-21.9 367-393 160 
a Mean age: 8-9 weeks. 
b N.D.. not determined. 
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Table II 
Protein content and enzymic activities in islet and liver homogenates 
Control Diabetes P 
Volume 316, number 3 
Mice 
Pancreatic islets 
Protein @g/islet) 
m-GDH (fmol/mm per &g) 
Glutamate debyd~og~nase (pmoYmin per gg) 
2Xetoglutarate debydrogen~ <pmolfmin per pg) 
Liver 
Pmtein (m&g wet weight) 
m-GDH ~fmo~min per @g) 
m-GDH ~frno~rnln per &? 
Glutamate dehydrogen~e ~prno~rnl~ per ,glbg) 
Z-Ketoglutarate dehydrogenase (pmol/min per #g) 
Glutamate-pyruvate ransaminase @moUrnin per ,& 
Glutamate-oxalacetate transaminase (pmollmin per p,lg) 
0.63 + 0.13 (7) 0.68 + 0.07 (8) 
143.1 r 18.0 (7) 60.5 + 13.8 (8) 
31.6 It 4.2 (7) 27.3 + 1.2 (8) 
I.37 + 0.24 (7f 1.30 Zb 0.37 (8) 
198.6 2 17.6 1%) 
7.64 4 OS0 (2X) 
422 It 34 (27) 
23.6 + 0.5 (27) 
0.20 + 0.01 (28) 
134.8 ?r: 5.5 (28) 
130.9 zf 7.2 (28) 
f9X.3 r 4.1 (24) 
7.26 a 0.87 f24) 
379 + 4? (24) 
23.8 f 0.5 (24) 
0.37 + 0.03 (24) 
165.1 f 5.4 (23) 
162.6 * 7.3 (23) 
N.S. 
<0.005 
N.S. 
N.S, 
N.S. 
N.S. 
NS. 
NS. 
~O.t.JUl 
<O.UOI 
<0.005 
-- 
The activity of FAD-linked glycerophosphate dehydrogenase (m-GDH) was measured by either a radioisotopic procedure” or calorimetric 
techniqu$, P values are not provided when there was no significant difference (N.S.) between control and diabetic mice. 
months, diffe~~tial ceII counting of the endocrine islet 
cells demonstrates that the frequency of B-celb is barely 
decreased in the diabetic a~irn~~ ay~ragin~ 72.9 2 3.3% 
as compared to 80.6 + 1.2% in the control mice [25]. 
Likewise, the decreased activity of m-GDH in pancre- 
atic islets of dbldb mice is unlikely to represent he eon- 
sequence of hyperglycemia. No decrease in the activity 
of this enzyme is found in islets exposed far a prolonged 
period to high concentrations of n-glucose, whether in 
vitro or in vivo [ 15,16], The islet enzymic defect cannot 
be blamed on a generalized decrease in the activity of 
a11 mit~hondrial dehydro~enases~ as documented by 
our measurement of glutamate de~~dro~e~a~e and 2- 
k~toglutarate dehydrogena~ in islet bomogeRates. 
It is quite conceivable, therefore, that the def&iency 
of islet m-GDH represents a primary factor contribut- 
ing to the alteration of B-cell function in this model of 
hereditary diabetes. A comparable situation was re- 
cently documented in another animal model of inherited 
non-insulin-dependent diabetes, namely in GK rats 
[27,28]. In both cases, the decrease in m-GDH activity 
was restricted to B-cells and not observed in liver homo- 
genates. It is ~ro~osed~ therefore, that a site-specify 
deficiency of m-GDH might represent a far-from-un- 
common causal or contr~b~ti~~e factor in the pathogene- 
sis of eon-insulin-dependent diabetes mellitus. 
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